Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CAR-T
Sort By
Newest First
1 / 3
1 / 3
Biopreservation
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Vitrafy
PAO-10-24-RTM-02
Nov 04, 2024
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33
Nov 01, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
Sep 05, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03
Feb 23, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
PAO-12-022-CL-04
Jan 03, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
Nov 11, 2022
CRISPR Research Innovation
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Gladstone Institutes
PR-M08-22-05
Aug 25, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03
Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06
Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04
Jun 24, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
Mar 30, 2022
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
Juntendo University
PR-M01-22-23
Jan 31, 2022
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14
Oct 22, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05
May 27, 2021
Cell and Gene Therapy
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
Jason Rahal
Nice Insight
PA1009
Apr 21, 2021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
Gregory Frost, Ph.D.; Sid Kerkar, M.D.
EXUMA Biotechnology
PAO-01-21-CL-06
Feb 04, 2021
The Future of Healthcare
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
Inceptor Bio
PAP-Q4-20-RT2-002
Dec 09, 2020
In Conversation
Novel Off-The-Shelf Targeted Cell Therapies
Gary Lord; Dago Caceres; David Alvaro, Ph.D.; Sonny Hsiao, Ph.D.
Dow Chemicals
PAP-Q2-20-CL-021
Jul 01, 2020
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
WuXi Advanced Therapies
PR-M05-20-NI-025
May 18, 2020
CAR-T
Leveraging Natural Killer Cells as CAR-T Therapies
Filippo Petti
Celyad
PAP-Q4-19-CL-013
Dec 06, 2019
